Dmitry Balyasny’s Outset Medical OM Stock Holding History

Dmitry Balyasny’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-116,291	Closed	-$1.64M	–	3429
2025 Q3	$1.64M	Sell	116,291 -26,869	-19%	-$419K	﹤0.01%	1899
2025 Q2	$2.75M	Buy	+143,160	New	+$2.23M	﹤0.01%	1572
2024 Q3	–	Sell	-1,124	Closed	-$64.9K	–	3036
2024 Q2	$64.9K	Buy	+1,124	New	+$55.1K	﹤0.01%	2427
2022 Q1	–	Sell	-3,947	Closed	-$2.73M	–	2739
2021 Q4	$2.73M	Buy	+3,947	New	+$2.92M	0.01%	1091

Other funds holding OM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

Dmitry Balyasny's OM Position: Q4 2025 in Review

Dmitry Balyasny sold out of Outset Medical (OM) in Q4 2025, closing a stake of 116,291 shares — an estimated $1.64M sold.

Dmitry Balyasny first reported a position in OM in Q4 2021 and held it in 4 quarters. The position peaked at $2.75M in Q2 2025. 100 funds tracked by Wall St. Rank hold OM as of Q4 2025.

Dmitry Balyasny reported no remaining Outset Medical position as of Q4 2025 after selling out during the quarter.
Dmitry Balyasny sold 116,291 Outset Medical shares in Q4 2025, an estimated $1.64M.
Dmitry Balyasny first reported a position in Outset Medical in Q4 2021 and held it in 4 quarters.
Dmitry Balyasny's Outset Medical position peaked at $2.75M in Q2 2025.
100 funds tracked by Wall St. Rank held Outset Medical as of Q4 2025.

Based on Balyasny Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.